Open AccessTreatment Outcomes in AIDS-Related Diffuse Large B-cell Lymphoma in the Setting Roll Out of Combination Antiretroviral Therapy in South Africa
Author(s) -
Pieter de Witt,
Deborah Johanna Maartens,
Thomas S. Uldrick,
Gerhard Sissolak
Publication year - 2013
Publication title -
jaids journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3182a03e9b
Subject(s) - medicine , vincristine , international prognostic index , chop , tuberculosis , diffuse large b cell lymphoma , prednisone , lymphoma , cyclophosphamide , surgery , chemotherapy , oncology , pathology
Long-term survival for patients with AIDS-related diffuse large B-cell lymphoma (DLBCL) is feasible in settings with available combination antiretroviral therapy (cART). However, given limited oncology resources, outcomes for AIDS-associated DLBCL in South Africa are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom